|    |  Home | Sitemap | Contact Us     Search Ranbaxy for  
  Quick Links
 
 
   
   
 
    
 
     
 
   
 
 


Home
> Investor Relations > Financials > Quarterly Results
 



Untitled Document
R A N B A X Y
LABORATORIES LIMITED
Standalone Unaudited  Financial Results (Provisional)
for three months ended 31st March, 2009
 
Rs Millions
Particulars Three months ended Year
ended
31/12/2008
Audited
31/03/2009 31/03/2008
Sales    
-  Domestic 3,651.16 3,487.74 15,453.06
-  Exports 4,406.60 6,479.44 27,940.57
Sales 8,057.76 9,967.18 43,393.63
Less : Excise duty 35.55 94.32 310.01
Net Sales 8,022.21 9,872.86 43,083.62
Other Operating Income 199.08 269.75 1,637.85
Total Expenditure 8,874.71 7,849.64 42,218.11
(Increase)/Decrease in stock in trade (1,006.99) 401.27 (1,155.89)
Consumption of Material 3,631.19 3,178.04 15,736.83
Purchase of Traded Goods 924.18 779.34 4,211.64
Employee Cost 1,457.40 1,209.49 4,730.25
Foreign Exchange Loss/(Gain) 560.00 (549.00) 2,562.32
Depreciation & Amortisation 290.10 321.49 1,544.69
Other Expenses  3,018.83 2,509.01 14,588.27
Balance (653.42) 2,292.97 2,503.36
R & D Expenditure 1,046.80 906.50 4,155.46
(Loss)/Profit from Operations before Other Income, Interest & Exceptional Items (1,700.22) 1,386.47 (1,652.10)
Interest & Other Income 413.54 58.05 2,096.23
(Loss)/Profit before Interest & Exceptional Items (1,286.68) 1,444.52 444.13
Finance cost    
Interest 133.30 262.46 1,458.28
Foreign exchange Loss on loans 1,242.51 763.20 7,474.52
(Loss)/Profit after Interest but before Exceptional Items (2,662.49) 418.86 (8,488.67)
Exceptional Items    
Loss on fair valuation of derivatives (9,188.00) (7,702.14)
Profit on sale of Land and Building   895.16  
(Loss)/Profit from Ordinary Activities before  Tax (11,850.49) 1,314.02 (16,190.81)
Tax (4,072.71) 279.80 (5,742.79)
Net (Loss)/ Profit from Ordinary Activities after Tax (7,777.78) 1,034.22 (10,448.02)
Paid - up Equity Share Capital  2,101.85 1,865.77 2,101.85
(Face value of Rs. 5 each)    
Reserves excluding revaluation reserves                 33,309.22
(Loss)/Earnings Per Share (Rs.)          
Before exceptional items    
Basic (4.07) 1.01 (27.29)
Diluted (4.07) 1.01 (27.29)
After exceptional items          
Basic (18.50) 2.77 (27.29)
Diluted (18.50) 2.77 (27.29)
Public shareholding #    
 -  Number of shares       145,199,916 233,300,117 144,431,309
-  Percentage of shareholding 34.54% 62.52% 34.36%
   
Promoters and Promoter Group Share holding  
a) Pledged / Encumbered  
- Number of Shares NIL * NIL
- Percentage of shares (as a % of the total shareholding of  
   promoter and promoter group) - - -
- Percentage of shares (as a % of the total share capital of - - -
   the company)  
b) Non - Encumbered  
- Number of Shares 268,111,323 * 268,111,323
- Percentage of shares (as a % of the total shareholding of  
   promoter and promoter group) 100% - 100%
- Percentage of shares (as a % of the total share capital of the company) 63.92% - 63.92%
       
# Aggregate Public shareholding as defined under Clause 40A of the Listing Agreement (excludes shares held by   Promoters and GDRs)
* Daiichi Sankyo Company, Limited became promoters of the Company effective November 7, 2008,